MedTrace Logo

Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer

NCT02706743 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2016-09-13

No results posted yet for this study

Summary

The aim of this study was to assess the impact of adjuvant radioactive iodine therapy on the quality of life(QOL) in differentiated thyroid cancer patients and to identify independent factors affecting changes in the QOL.

Conditions

  • Thyroid Neoplasms

Sponsors & Collaborators

  • Southern Medical University, China

    lead OTHER

Principal Investigators

  • Sun Y Gang, Master · Zhujiang Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02706743 on ClinicalTrials.gov